- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06822777
RISE for Nurse Preceptors
October 21, 2025 updated by: AdventHealth
A Randomized Controlled Trial of RISE for Nurse Preceptors
The purpose of this study is to determine whether RISE for Nurse Preceptors has a significant impact on nurse preceptors' burnout, resilience, insight, self-compassion, and empowerment, as well as mental well-being, in their personal lives and their working environment.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
124
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Orlando, Florida, United States, 32804
- AdventHealth
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Adult ≥ 18 years old
- Licensed as an RN
- Employed by AdventHealth Rocky Mountain Region
- Completion of the AdventHealth preceptor training
- Has precepted ≥ 48 hours within the past calendar year in an AdventHealth hospital setting or outpatient emergency center
- Able to speak, read, and understand English fluently
- Able to provide informed consent
- Willing and able to comply with all study procedures and requirements for the duration of the study.
Exclusion Criteria:
- Has precepted < 48 hours within the past calendar year
- Does not pass the brief risk assessment in the pre-intervention introduction meeting with the LMHC facilitator
- Unwilling or unable to comply with all study procedures and requirements for the duration of the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Intervention group will attend the RISE for Nurse Preceptors program, which consists of nine 90-minute weekly psychoeducational group sessions facilitated by a licensed mental health counselor (LMHC)
|
Psychoeducational group program designed to impact resilience, insight, self-compassion, and empowerment
|
|
Active Comparator: Wait-list control group
Control group will attend the RISE for Nurse Preceptors program after the 6-month wait-list period
|
Psychoeducational group program designed to impact resilience, insight, self-compassion, and empowerment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Professional Quality of Life Scale
Time Frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
30-item questionnaire with the following response categories: 1=never, 2=rarely, 3=sometimes, 4=often, 5=very often
|
Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Posttraumatic Growth Inventory
Time Frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
21-item questionnaire with a scale of 0-5, with 0 meaning I did not experience this change as a result of my crisis; and 5 meaning I experienced this change to a very great degree as a result of my crisis
|
Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
|
Brief Resilience Scale
Time Frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
6-item questionnaire with the following response categories: 1=strongly agree, 2=disagree, 3=neutral, 4=agree, 5=strongly agree
|
Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
|
Self-Reflection and Insight Scale
Time Frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
20-item questionnaire with a scale of 1-6; with 1 meaning strongly disagree; and 6 meaning strongly agree
|
Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
|
Self-Compassion Scale - Short Form
Time Frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
12-item questionnaire with the following response categories: 1=almost never, 2, 3, 4, 5=almost always
|
Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
|
Psychological Empowerment Instrument
Time Frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
12-item questionnaire with a scale of A-G, with A meaning very strongly disagree; and G meaning very strongly agree
|
Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
|
General Self-Efficacy Scale
Time Frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
10-item questionnaire with the following response categories: 1=not at all true, 2=barely true, 3=moderately true, 4=exactly true
|
Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
|
Perceived Stress Scale
Time Frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
10-item questionnaire with the following response categories: 0=never, 1=almost never, 2=sometimes, 3=fairly often, 4=very often
|
Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
|
Moral Injury Outcomes Scale
Time Frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
14-item questionnaire with the following response categories: 0=strongly agree, 1=disagree, 2=neither agree or disagree, 3=agree, 4=strongly agree
|
Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
|
Brief COPE
Time Frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
28-item questionnaire with a scale of 1-4, with 1 meaning I haven't been doing this at all; and 4 meaning I've been doing this a lot
|
Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
|
Generalized Anxiety Disorder - 2 item scale
Time Frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
2-item questionnaire with the following response categories: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day
|
Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
|
Patient Health Questionnaire - 2 item
Time Frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
2-item scale with the following response categories: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day
|
Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
|
Preceptor Self-Assessment Tool
Time Frame: Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
40-item scale with the following response categories: 1 (lowest), 2 (low), 3 (average), 4 (high), 5 (highest).
|
Baseline, endpoint, and 1-, 3-, and 6-month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Amanda T Sawyer, PhD, AdventHealth
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.
- Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: assessing the ability to bounce back. Int J Behav Med. 2008;15(3):194-200. doi: 10.1080/10705500802222972.
- Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003 Nov;41(11):1284-92. doi: 10.1097/01.MLR.0000093487.78664.3C.
- Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007 Mar 6;146(5):317-25. doi: 10.7326/0003-4819-146-5-200703060-00004.
- Raes F, Pommier E, Neff KD, Van Gucht D. Construction and factorial validation of a short form of the Self-Compassion Scale. Clin Psychol Psychother. 2011 May-Jun;18(3):250-5. doi: 10.1002/cpp.702. Epub 2010 Jun 8.
- Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997;4(1):92-100. doi: 10.1207/s15327558ijbm0401_6.
- Tedeschi RG, Calhoun LG. The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996 Jul;9(3):455-71. doi: 10.1007/BF02103658.
- Bailey AK, Sawyer AT, Robinson PS. A Psychoeducational Group Intervention for Nurses: Rationale, Theoretical Framework, and Development. J Am Psychiatr Nurses Assoc. 2023 May-Jun;29(3):232-240. doi: 10.1177/10783903211001116. Epub 2021 Jun 22.
- Litz BT, Plouffe RA, Nazarov A, Murphy D, Phelps A, Coady A, Houle SA, Dell L, Frankfurt S, Zerach G, Levi-Belz Y; Moral Injury Outcome Scale Consortium. Defining and Assessing the Syndrome of Moral Injury: Initial Findings of the Moral Injury Outcome Scale Consortium. Front Psychiatry. 2022 Jul 5;13:923928. doi: 10.3389/fpsyt.2022.923928. eCollection 2022.
- Sawyer AT, Bailey AK, Green JF, Sun J, Robinson PS. Resilience, Insight, Self-Compassion, and Empowerment (RISE): A Randomized Controlled Trial of a Psychoeducational Group Program for Nurses. J Am Psychiatr Nurses Assoc. 2023 Jul-Aug;29(4):314-327. doi: 10.1177/10783903211033338. Epub 2021 Jul 23.
- Sawyer AT, Tao H, Bailey AK. The Impact of a Psychoeducational Group Program on the Mental Well-Being of Unit-Based Nurse Leaders: A Randomized Controlled Trial. Int J Environ Res Public Health. 2023 Jun 2;20(11):6035. doi: 10.3390/ijerph20116035.
- Grant, A. M., Franklin, J., & Langford, P. (2002). The Self-Reflection and Insight Scale: A new measure of private self-consciousness. Social Behavior and Personality, 30(8), 821-836.
- Sawyer AT, McManus K, Bailey AK. A mixed-methods pilot study of a psychoeducational group programme for nurse managers during the COVID-19 pandemic. J Nurs Manag. 2022 Nov;30(8):4126-4137. doi: 10.1111/jonm.13881. Epub 2022 Nov 13.
- Spreitzer, G. M. (1995). Psychological empowerment in the workplace: Dimensions, measurement, and validation. Academy of Management Journal, 38(5), 1442-1465.
- Stamm, B. H. (2009). Professional Quality of Life: Compassion Satisfaction and Fatigue Version 5 (ProQOL). http://www.proqol.org.
- L'Ecuyer K, Subramaniam DS, Reansing C, DuBois JC. Psychometric Testing of the Preceptor Self-Assessment Tool (PSAT)-40 for Nursing Preceptors. J Contin Educ Nurs. 2022 Nov;53(11):491-499. doi: 10.3928/00220124-20221006-06. Epub 2022 Nov 1.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2025
Primary Completion (Estimated)
February 28, 2026
Study Completion (Estimated)
February 28, 2026
Study Registration Dates
First Submitted
February 7, 2025
First Submitted That Met QC Criteria
February 11, 2025
First Posted (Actual)
February 12, 2025
Study Record Updates
Last Update Posted (Estimated)
October 22, 2025
Last Update Submitted That Met QC Criteria
October 21, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2251716
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.